A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.

Authors :: Zeidner JF
Lin TL
Vigil CE
Fine G
Yair Levy M
Nazha A
Esteve J
Lee DJ
Yee K
Dalovisio A
Wang ES
Bergua Burgues JM
Schriber J
Litzow MR
Frankfurt O
Castillo TBD
Bhatt VR
Bhatnagar B
Mehta P
Dillon R
Vicente MV
Anthony S
Bearss D
Montesinos P
Douglas Smith B
Source :: Blood cancer journal [Blood Cancer J] 2021 Oct 30; Vol. 11 (10), pp. 175. Date of Electronic Publication: 2021 Oct 30.
Publication Year :: 2021

Subjects :: Adolescent
Adult
Aged
Cytarabine administration & dosage
Female
Flavonoids administration & dosage
Humans
Leukemia, Myeloid, Acute blood
Leukemia, Myeloid, Acute drug therapy
Male
Middle Aged
Mitoxantrone administration & dosage
Piperidines administration & dosage
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor blood
Myeloid Cell Leukemia Sequence 1 Protein

Full Text Access

Tools